HF 753 (see companion bill SF 272) – Minnesota

Status: Inactive / Dead
Year Introduced: 2019
Link: https://www.revisor.mn.gov/bills/bill.php?b=House&f=HF0753&ssn=0&y=2019

Price gouging by manufacturer or wholesale drug distributor prohibited; Board of Pharmacy, commissioner of human services, and health plan companies allowed to notify the attorney general of prescription drug price increases; attorney general authorized to obtain drug pricing information and take action against manufacturers and wholesalers for price increases; and civil penalties imposed.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found